This inventor holds 1 USPTO granted patent. Top assignee: Beijing University of Technology. Active years: 2000.
Company Filing History:
Years Active: 2000
Title: Ian David Rae: Innovator in Hypoglycaemic Peptides
Introduction
Ian David Rae is a notable inventor based in Mount Waverley, Australia. He has made significant contributions to the field of biochemistry, particularly in the development of insulin-potentiating compounds. His work focuses on addressing critical health issues related to diabetes management.
Latest Patents
Ian David Rae holds a patent for his invention titled "Hypoglycaemic Peptides." This invention relates to novel insulin-potentiating hypoglycaemic compounds that have the potential to improve blood sugar regulation in diabetic patients. He has 1 patent to his name, showcasing his innovative approach to medical science.
Career Highlights
Ian is affiliated with the Beijing University of Technology, where he continues to advance his research in the field of hypoglycaemic compounds. His academic and professional journey reflects a commitment to improving health outcomes through scientific innovation.
Collaborations
Ian has collaborated with esteemed colleagues, including Milton T Hearn and Frank Man-Woon Ng. These partnerships highlight the collaborative nature of scientific research and the importance of teamwork in achieving groundbreaking results.
Conclusion
Ian David Rae's contributions to the field of hypoglycaemic peptides exemplify the impact of innovative thinking in medicine. His work not only advances scientific knowledge but also holds promise for improving the lives of individuals with diabetes.